Daewoong Bio file appeal, “GLIATAMIN and GLIATILIN has no similarity in trademark”

Daewoong Bio said on the 30^th “Cognition-enhancing GLIATAMIN and Italfarmaco’s GLIATILIN have no similarity in appearance, name and concept. We’ll immediately file an appeal.”

It was the company’s official position about the lost case on the GLIATAMIN trademark nullification trial, recently ruled by the Patent Court, and decided to lodge an appeal.

An issue of the trial is if the two product ...